Aberdeen Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Aberdeen Group’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-423,869	Closed	-$966K	–	978
2024 Q2	$966K	Hold	423,869	–	–	﹤0.01%	822
2024 Q1	$1.83M	Hold	423,869	–	–	﹤0.01%	784
2023 Q4	$1.29M	Buy	+423,869	New	+$796K	﹤0.01%	816

Aberdeen Group's GTHX Position: Q3 2024 in Review

Aberdeen Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 423,869 shares — an estimated $966K sold.

Aberdeen Group first reported a position in GTHX in Q4 2023 and held it in 3 quarters. The position peaked at $1.83M in Q1 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Aberdeen Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Aberdeen Group sold 423,869 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $966K.
Aberdeen Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
Aberdeen Group's G1 Therapeutics, Inc. Common Stock position peaked at $1.83M in Q1 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Aberdeen Group's 13F filing for Q3 2024, filed 25 Oct 2024.